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Abstract. The genes of a fertilized ova contain all of the information needed to con- 
struct an eye, regulate its function, maintain it in working order, decipher its signals 
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any eye diseases are familial and fol- 
low a Mendelian pattern of inheritance. 
Until recently, the gene was a 
theoretical unit which did not permit fruitful 
speculation of the biological mechanisms. 
The appreciation of the biological basis for 
genetic disease has only been realized since 
the establishment of a molecular model of 
genetic inheritance in microorganisms. The 
intensive study of microorganisms permitted 
a sound framework which has led to the pres- 
ent era of dissection of the genes of higher 
organisms. The recent insights into the 
organization and structure of human genes 
permits understanding of the normal and ab- 
normal genetic function and development - 
including that of the eye. 
It is difficult to understand the genetic 
basis of eye structure and function unless we 
analyze genes in informational and physical 
terms. The genes of a fertilized ova contain all 
of the information needed to construct an eye, 
regulate its function, maintain it in working 
order, decipher its signals, and store the 
visions it gathers. When we consider the 
volumes of books needed to understand some 
of the simpler aspects of ophthalmology, the 
economy and efficiency of genes is astound- 
ing. The period at the end of this sentence 
could easily accommodate 700 sets of genes. 
Within a single set of genes there is the 
capability to organize 5 X lo’* bits of infor- 
mation. In computer terms, 5 X 1012 bits of 
information would be equal to about 250,000 
pages or 500 volumes of printed data. 
The information of genetics is written with 
a four-letter alphabet in a straight line just as 
a sentence is written.48 The letters of genetic 
sentences are represented by the four nucleic 
acid bases - adenine, thymidine, cytosine, 
and guanine (A, T, C, G). It takes three 
letters to form a translatable word. The 
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letters are linked by ribose phosphate bonds 
to form a long strand of DNA in the form of a 
chromosome. Each chromosomal strand con- 
tains about 100,000,000 letters and averages 
three centimeters in length. In terms of our 
written language, each chromosome would be 
a separate volume of information. There are 
46 chromosomes in each cell for a combined 
length of about 1% meters containing 4.6 
billion letters. The packaging of chromosome 
strands is a complex cellular problem since 
strands total 1.5 million microns in length 
and are packaged in the nucleus which is less 
than 10 microns in diameter. 
The genes are transcribed in the nucleus 
from DNA to RNA; in the cytoplasm they 
are translated to functioning proteins. Often 
these proteins are enzymes which perform a 
specific task in the cell. Fig. 1 shows this 
transfer of information. 
Defects which can occur in this information 
can be schematically represented by a 
sentence composed of English three-letter 
words. Since all genetic words are exactly 
three letters long, no spacing is required as 
long as there is a cue for beginning. For in- 
stance, in the following sentence, the capital 
letter is a cue for the sentence to begin. 
“ThebigreddogranoutHerpupdidtoo” 
becomes: 
“The big red dog ran out. Her pup did too.” 
If a letter, as in a sentence (or a base as in a 
cell) were replaced, the meaning of the 
sentence would change. Changing the letter g 
to h the sequence would be: 
“ThebigredhogranoutHerpupdidtoo” 
becomes: 
“The big red hog ran out. Her pup did 
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“The bir edd ogr ano ut. Her pup did too.” 
The spurious insertion of a letter would bring 
about the same result. The change of any part 
of the code will change the rest of the sentence 
until the translation mechanism finds another 
beginning cue to reorient itself. Sometimes 
there are large deletions which remove the en- 
tire sentence or most of the sentence. 
Extensive work with bacteria has es- 
tablished that a gene is a code for an enzyme 
which performs a specific function. Three 
bases specify an amino acid by transcription 
through an intermediate message. When the 
base is changed, the amino acid of the enzyme 
changes. Some changes cause disease, others 
are inconsequential. 
Mammalian Genes 
In the few mammalian genes which have 
been directly visualized, the structure of a 
gene is more complicated than this simple 
code since there are two further aspects of 
higher genes. The gene is surrounded by se- 
quences which are not transcribed into 
messages and are called spacers; and within 
the code for the gene are several insertions or 
introns. In order for the final enzyme to be 
made, the sequence within the gene (or in- 
tron) must be clipped out. Figs. 2 & 3 il- 
lustrate the way that this is probably done. 
Such an elaborate system was never imagined 
until it became possible to directly visualize 
genes. Now that we know that these inser- 
FIG. 1. (a) Bases represented as G, 
C, A, or T are linked together by a 
phosphodiester deoxyribose back- 
bone. Two strands are twisted to- 
gether in a double helix as strategy for (a) GATACGATTGATCG 
replication. (b) One of the two strands DNA in nucleus 
is transcribed in the nucleus to form a CTATGCTAACTAGC 
single stranded ribose form or (b) CUAUGCUAACUAGC 
messenger RNA. The mRNA is used --- RNA in cytoplasm with initiation 
as an informational tape to program initiaGYsigna1 initiation signal 
the protein machinery -of - the 
ribosome. The mRNA specifies the (c) leucine-threonine-serine amino acid sequence of an 
beginning of the program and the ex- 
enzyme 
act order of amino acids. (c) The CUA 
order of the amino acids determined 
ACU AGC - codons for specific amino 
the three dimensional shape and 
sequence of enzyme 
catalytic activity of the enzyme. 
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CUA ACU AGC 
FIG. 2. (a) In the mammalian gene, the transcribed information is preceded by a string of bases which 
are not transcribed and therefore are not part of the coding system. This DNA is termed Untrmscribed 
spacer and comprises about ‘/z of the DNA sequences of the genes isolated. (b) The DNA is transcribed 
and a series of A’s are added to the right hand side of the message, the poly A signal. The series of A’s 
may be added so that the message is recognized as such and to insure its proper handling and delivery to 
the proper site in the cytoplasm. (c) The sequences which intervene in the code (the introns) are then ex- 
cised and a message is presented to the ribosome which permits translation to the correct protein se- 
quence. In comparison to the system in Figure 1, there is much more DNA required for a given protein 
sequence. The greater complexity of the processing permits more steps for modification or regulation and 
also allows for more errors. 
tions or introns are present, it is thought that 
they are important regulatory devices which 
assure that the information is used only at the 
proper time and place. For instance, 
hemoglobin is to be made in the red blood cell 
and not in other places. Designated cells use 
certain genes in the same way that only televi- 
sion sets with a decoder can unscramble 
signals sent on the pay-television channel. All 
of the homes receive the same signal but only 
those homes with a decoder can utilize the in- 
formation sent to it. 
Spacers may be related to a higher level of 
regulation which is not yet understood. Or 
AYG “tA 
they may be related to the packaging - the 
spacers may be needed to package the enor- 
mous amount of DNA. Or the spacers may be 
I , 
related to another feature of mammalian 
genes which had not been expected, that is, 
the large number of repetitious DNA se- 
quences. Our cells contain some sequences 
which are repeated several thousand times. 
Since it requires only one copy of a gene to 
make an enzyme, it is apparent that much of 
our informational system is not used for 
FIG. 3. An illustration of the processing steps 
which begin with a gene and end with a functional 
coding proteins. Spacers may be used to form protein. The steps are those given in Figure 2. 
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KARYOTYPE 
--- - __ -_. _ - 
13 14 15 16 
FIG. 4. Karyotype of the human. The banded chromosomes of the human permit 
the identification of each chromosome and the subdivision of each. Arrow at 
chromosome 11 and 13 indicate the positions of deletions which lead to AGR and 
retinoblastoma respectively. 
signals to the machinery of the cells so that 
the information can be cataloged, as we might 
use titles to a chapter. 
Recombinant DNA 
Since specific genes have been directly 
visualized, it may be important to explain 
how this advance was made. The ability to see 
the structure of a single gene and relate it to a 
single activity has been made possible by the 
ability to fractionate the entire set of genes. 
This is done with recombinant DNA 
technology. 
A single human cell contains enough DNA 
for six million genes which are connected on 
23 pairs of chromosomes. Therefore, any 
given gene is only one part in six million. Un- 
til recombinant techniques were developed, it 
was technically impossible to chemically 
locate a specific single gene or to do 
biochemical analysis of a single gene. With 
recombinant DNA technology, the genes are 
broken up from long strands into pieces about 
the size of two or three genes. These small 
fragments are inserted into the much simpler 
genetic strands of plasmids. These organisms 
themselves contain only two or three genes 
and are so simple that they exist only within 
other organisms such as bacteria. The human 
genes within the simple organisms are in- 
troduced into a bacterial cell which will 
replicate and enormously amplify the gene. 
Once the billions of copies of the gene are 
made, the genes can be viewed by electron 
microscope to detect their shape (Fig. 4). It is 
possible to see genes in which there has been a 
major change. For instance, it is possible to 
see when parts of a gene are missing or 
rearranged or inverted. In alpha Thalassemia 
a large section of the alpha chain is missing. 
Also, at this purity it is possible to determine 
the exact base sequence. Knowing the base 
sequence, one can predict the protein which is 
coded by the gene. For instance, if a par- 
ticular gene is isolated in the manner il- 
lustrated above, the ability to sequence the 
isolate permits one to detect which gene is its 
neighbor and has been isolated with it. This is 
a direct means of identifying gene organiza- 
tion. 
Chromosome Structure 
One further level of gene organization can 
be studied by the light microscope, the 
FIG. 5. A purified human ribo- 
somal gene. This gene is inserted into 
a bacteriophage. It is seen at 100,000 
X magnification. The human gene 
begins and ends at the bifurcation in- 
dicated by the arrows. This gene 
forms a Y shaped structure which 
may be important for its function. 
chromosomal level. Single genes are much 
too small to visualize at the level of the light 
microscope. However, the light microscope 
permits us to see a complete chromosome. 
Each chromosome appears to consist of 
bands when treated with mild denaturing 
agents (Fig. 5). It is likely that any visible 
chromosomal change is a rearrangement of 
several hundred genes. The genes coding for 
enzymes may be very unevenly distributed 
over the chromosome since large parts of 
some chromosomes can be deleted with no 
effect while small changes in other areas of 
the chromosome cause serious and 
widespread damage. Presently, it is not 
known exactly how a chromosome is given its 
particular shape, but the DNA of the 
chromosome appears to be built on a protein 
scaffold. 
There have been two major means of study- 
ing the function of chromosomes. The first 
has been to clinically correlate chromosome 
changes with both disease and hereditary 
patterns. The second method has been to 
isolate individual chromosomes from their 
original cell and transfer them to a different 
cell where their action can be observed in- 
dependent of the other chromosomes. 
The general lessons learned from clinical 
correlations tell us about the nature of gene 
organization at the chromosome level. 
Chromosome defects cause widespread men- 
tal retardation. Chromosome changes do not 
affect the metabolic reactions in a person so 
that we can surmise that the chromosome 
organization is not an important unit in 
regulating metabolic activity, but is impor- 
tant in determining the final form of 
anatomical structure and brain development. 
The second method of studying chromo- 
somes is called somatic cell hybridization. If 
cells from a mouse are grown in culture with 
cells from a human, the two cells can be fused 
together. A Sendai virus added to the culture 
will cause the nuclei of the cells to fuse and 
form a new cell with chromosomes from both 
organisms. The new cell then tends to lose the 
human chromosomes and as they divide they 
retain relatively few human chromosomes. 
The cells can then be tested for specific en- 
zyme activity. Correlations are then made 
between chromosomes present and enzyme 
activity. For instance, if whenever the human 
enzyme thymidine kinase is present in the 
cell, only the human chromosome #17 is 
present; it can be concluded that chromosome 
#I7 contains the gene for thymidine kinase. 
This relationship can be shown even more 
clearly if the mouse cell does not have a 
thymidine kinase gene and the hybrids are 
grown in a culture medium which requires the 
cellular production of thymidine kinase for 
the cell to survive. The mouse cell depends on 
a thymidine kinase molecule and can only 
grow when it has received a human #17 
chromosome. Under these culture conditions 
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the mouse cell tends to lose all of the human 
chromosomes except the essential one. 
The techniques of somatic cell hybridiza- 
tion combined with correlating inheritance 
of disease with familial inheritance of chro- 
mosomes has resulted in the chromosomal 
location of over 300 genes. These include 
the immunity genes on chromosome 6, hemo- 
globin alpha on chromosome 4 and the beta 
and gamma hemoglobin chains on chromo- 
some 11. About 1300 diseases are established 
as genetic and 17% of these can be assigned to 
chromosomal location. Because better map- 
ping makes future mapping easier, we would 
expect the chromosome map to continue to 
rapidly increase in detail. 
The biological basis of genetic eye disease 
is based on the facts briefly outlined above. 
The number of genes present in the human 
determine the number of genetic diseases 
possible. The more components there are to a 
system, the more things that can go wrong. 
The number of genes required for a human to 
function normally is not known. Although the 
cell contains enough DNA for 6,000,OOO 
genes, we do not know how much of the DNA 
is essential. Many genetic abnormalities are 
inviable and are never seen. Therefore, the 
number of genetic diseases which allow the 
formation of a fetus and are recognized are 
only a small proportion of all of the possible 
defects. According to the recent catalog of 
human genetic disease, there were about 28 11 
diseases which can be recognized and one-half 
of these have well documented mendelian in- 
heritance. The other half are strongly 
suspected of having a genetic basis. It is in- 
teresting that the Birth Defects Compendium 
lists 361 different diseases that affect the eye 
out of a total of 1005 birth defects listed. 
The best understood form of genetic dis- 
ease is that which results in a defective en- 
zyme which we can recognize. The structure 
of an enzyme is determined by the amino acid 
sequence of its enzyme. In turn, the amino 
acid sequence is determined by the base se- 
quence of the DNA. Any of the possible 
changes in the base sequence discussed above 
can cause a defective enzyme. In metabolic 
diseases, there are two major consequences of 
enzyme defects: 1) The accumulation of 
polymers which build up in the cell and in- 
terfere with cell function; or 2) the accumula- 
tion of small molecules that inhibit normal 
metabolic pathways. Table 1 lists some ex- 
amples of ophthalmologic diseases where the 
specific enzyme defect is known which fall 
into each of these categories. Characteristi- 
cally, the polymer storage diseases are 
associated with cataracts, cornea1 clouding, 
cherry red macula, and optic atrophy. The 
storage of mucopolysaccharides leads to cor- 
neal clouding. The storage of cerebrosides 
and gangliosides leads to a cherry red macula 
and optic atrophy. In the storage diseases, 
specific enzymes are responsible for the 
degradation of each polymer in steps. It is not 
known why these polymers need to be 
replaced, but it is obvious that degradation 
must balance production or the product will 
accumulate and destroy the structures. These 
diseases become progressively worse and the 
deterioration of function is related to the 
amount of abnormal storage. 
Accumulation of small molecules results in 
chemicals which inhibit other metabolic 
pathways. In each instance the abnormal 
metabolite can be identified in the blood or 
urine. The symptoms most associated with 
defects in metabolism are cataracts, pigmen- 
tary changes, neurological dysfunction, and 
retinitis. The discovery of these signs should 
lead to a screening of the urine and blood, es- 
pecially if they are associated with other 
neurological symptoms such as seizures or 
mental retardation. Because the polymers or 
small molecules rarely accumulate prior to 
birth, most children with severe metabolic 
diseases are normal at birth and eye signs 
may be the first signal of a metabolic disease. 
Chromosome Disease 
The molecular basis of chromosomal 
disease is more complicated. The 
chromosome is a large collection of genes 
which are active for varying durations during 
the genetic lifetime. In the life of a genotype 
the most critical time span is during em- 
bryogenesis. It is necessary that the 
chromosome contains the information for the 
timing of expression. An abnormality of a 
chromosome will do three things: 1) it will 
affect a specific set of genes; 2) it will interfere 
with information about the timing of expres- 
sion since chromosomes control the time in- 
terval of expression (e.g., 2nd to 4th day of 
embryogenesis); and 3) a deletion or a 
duplication will affect the amount of a gene 
product produced (i.e., genes are present in 
two doses so that deletion of a single 
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TABLE 1 
Enzyme Disorders and Corresponding Ocular Signs 
(Examples of Ophthalmic Genetic Diseases in which the Specific Enzyme Defect is Known) 
Disease 
STORAGE DISEASES 





















6 sulfate sulfatase 
arylsulfatase B 
Hexosidase A & B 
Hexosaminidase A 
Cornea1 dystrophic fundi 39 
cherry red macula; optic atrophy I 
Lenticular opacities 9 
retinal discoloration; degeneration 27 
Cornea1 opacity 25 
Cornea1 opacity 25 
Cornea] opacity 25 
Cornea] opacity 25 
Cherry red macula 29 
Cherry red macula 29 
Disease 
METABOLIC DISORDERS 
















Sulfite oxidase def. 
Tyrosinemia 
Homogentisic acid oxidase Dark sclera 
Tyrosinase Photophobia, nystagmus 
Pyruvate dicarboxylase Nystagmus 
Glucuronyl transferase Extraocular movement 
VI lysyl hydroxylase Retinal detachment 
galactokinase Cataracts 
galactose uridyl transferase Cataracts 
Cystathionine synthetase Dislocated lens 
Glycine Cell transport Optic atrophy 











branch chain decarboxylase Ophthalmoplegia; nystagmus I3 
sphingomyelinase Cherry red spot 41 
phytanic acid oxidase Retinitis pigmentosa 38 
tyrosine amino transferase Cornea1 dystrophy 16 
sulfite oxidase Extopia lentes 37 
tyrosine amino transferase lens opacity 17 
Disease 
CELLULAR DISORDERS 





Fish eye disease 
Lowe’s syndrome 
Menkes Syndrome 
sensitivity to X-ray 
chromosome exchange 
sensitive to UV light 
Lysosomal cystine 
serum triglycerides; very low 
density lipoproteins; high 
density lipoprotein 
abnormal amino acid transport 
copper retention 
Porphyria, Gunther type uroporphyrin I 
Conjunctival telangectasia 24 
Telangectasia of lids I8 
Retinitis pigmentosa 31 
Cornea1 crystals 35 
massive cornea] opacities 11 
cataracts 
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TABLE 2 
Examples of Chromosomal Defects with Ocular Signs 
Name of Syndrome 
4p--Wolf 
Sp--Cri du Chat 
Chromosome Defect 
deletion of chromosome #4 
deletion of chromosome #S 
Abnormalities of the Eye 
Epicanthus, strabismus, ptosis, oblique palpebral 
fissure, bypertelorism, iris and retinal coloboma. 
Oblique palpebral fissures, hypertelorism, epicanthal 
folds. 
l&-de Grouchy 
+ 13 Patau 
+ I8 Edwards 
+21 Down 
deletion of chromosome # 18 
47 chromosomes, extra # 13 
trisomy 13 
47 chromosomes, extra # 18 
trisomy 18 
47 chromosomes, extra #21 
trisomy 21 
Deeply set eyes, strabismus, glaucoma, nystagmus, 
optic atrophy, tapetoretinal degeneration. 
Epicanthal folds, iris colobomas, absent eyebrows, 
micropthalmos. 
Ptosis, epicanthal folds, micro-ophthalmus, cornea1 
opacities. 
Brushfield spots, oblique palpebral fissures, cataracts, 
strabismus. 
chromosome will decrease the dosage by 
50%). Different chromosomal defects could 
lead to the same abnormal increase of gene 
activity. An increase in the gene product 
would result if the number of genes were in- 
creased and also an increase in gene product 
would result if the time interval of activity 
were increased. The interval of activity for a 
specific gene may be critical. For instance, if 
it takes four weeks for the optic cup to fuse, 
the genes responsible for optic cup growth 
must be active for that amount of time. If ‘/2 
of the genes for optic cup growth are missing, 
the growth may be insufficient during that 
time interval for completion of optic cup 
development. This decrease in gene dosage 
would lead to coloboma formation. The same 
effect would result if the gene dosage were 
normal but the interval were shortened by in- 
terference with information about timing. 
Table 2 lists examples of the most common 
chromosomal syndromes and the eye abnor- 
malities associated with each of these. 
As we might expect, the chromosomal ab- 
normalities result in multiple defects since 
many genes are affected. If we agree that 
there are no less than 100,000 active genes, a 
change in 1% of the chromosomes would 
affect at least 1000 genes. The types of defects 
seen in chromosomal diseases can generally 
be classified as dysmorphic. There is an ab- 
normal shape or configuration to the struc- 
ture. Defects such as oblique palpebral 
fissures or hypertelorism reflect the relative 
growth of the bones surrounding and com- 
prising the orbit. The presence of epicanthal 
folds is seen when the relative growth of the 
nasal bridge is less than the growth of the skin 
of the medial portion of the eyelid. Some 
dysmorphic syndromes result when the 
relative growth of adjoining structures is ab- 
normal. This changed growth pattern may 
reflect a change of relative dosage of the 
genes which affect the adjoining structures. 
Hypertelorism could result if the genes for 
frontal bone growth were increased relative to 
those for the parietal and temporal bones. 
This disproportion would also result if the in- 
terval of growth for the frontal bone were in- 
creased in relation to the other facial bones. 
With advanced techniques in cytogenetics, 
it is possible to correlate small chromosomal 
changes with major genetic disease. The 
AGR triad of aniridia, ambiguous genitalia, 
and mental retardation is associated with an 
interstitial deletion of the short arm of 
chromosome 11. This syndrome also is 
associated with Wilms’ tumor. The segment 
of this chromosome which is associated with 
the triad is no more than 3% of the number 11 
chromosome. This chromosome comprises 
only 2.3% of the DNA of a cell. Therefore, 
only .03 (2.3%) or .07% of the genes are lost in 
the deletion which caused the AGR triad. If 
there are 100,000 structural genes, this means 
that we can see a chromosome change which 
represents only 70 genes. It should soon be 
possible to reIate specific genes to syndromes 
and thereby provide a molecular explanation 
for syndromes such as this. 
Retinoblastoma is associated with a small 
deletion of chromosome 13. This represents 
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no more than .3% of the chromosomal com- 
plement. The vast majority of patients with 
retinoblastoma do not have a chromosomal 
deletion. Those persons with a chromosomal 
deletion and retinoblastoma have mental 
retardation. Those with a large deletion often 
have physical defects as well. It is not sur- 
prising to find chromosomal defects 
associated with a malignancy if we consider 
that the chromosome contains genetic infor- 
mation about gene regulation. Certainly, the 
control of cell growth or lack of control is 
genetically determined. 
The fine mapping obtainable by 
cytogenetics might be compared to the fine 
structure analysis obtainable by recombinant 
DNA. The largest structure observed by EM 
and recombinant techniques is the phage - 
which has a size of 30 million Daltons or 
roughly 30 genes in size. The smallest band 
observable by light microscopy is about 
1,200,000,000 Daltons or 1,200 gene-size. 
Although the two methods are looking at 
quite different sizes in terms of gene organiza- 
tion, it is certainly predictable that the two 
lines of investigation will converge. Tech- 
nique of chromosome analysis will continue 
to be refined and the recombinant DNA 
technology will demonstrate ways to piece 
together small units of information. 
The ophthalmologic abnormalities which 
have a familial or genetic basis fall into two 
categories. The first includes those diseases 
that are determined by a single gene and can 
be explained by an altered enzyme or protein 
function. The second category includes those 
diseases that are associated with interactions 
between genes and result in disordered em- 
bryonic growth and cell control. With the sec- 
ond type, the relative activity and dosage of 
genes is important. The understanding of the 
first category will continue to increase as we 
learn more about the structure of mammalian 
genes. The understanding of the second 
category will be advanced when we better un- 
derstand the interactions of the many genes 
on a chromosome. Although the human 
chromosome is undergoing continua1 dissec- 
tion, there is still much to be learned about 
the ways genes work together to form a nor- 
mal fetus. 
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